跳至主要内容
临床试验/IRCT20170521034070N2
IRCT20170521034070N2已完成3 期

Comparison of the efficacy of 10-day vs. 12-day concomitant therapies for first-line Helicobacter pylori eradication in Iran.

Sari University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients with peptic ulcer disease according to endoscopic findings
  • Presence of Helicobacter pylori is proven in gastric tissue according to pathologic assessment of gastric biopsy
  • No history of previous treatment for Helicobacter pylori

排除标准

  • Breast feeding
  • History of gastrointestinal surgery
  • History of gastrointestinal malignancy
  • using anticoagulant drugs
  • using anti convulsion drugs

研究者

发起方
Sari University of Medical Sciences

相似试验